SULZBERGER GABRIELLE 1262388 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2023-05-15 | 2023-05-15 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 11.0 | 0.66 | 0.0 | 434.51 | Direct | Common Stock | ELI LILLY & CO | code A | 1659.0 | 949.27 (LLY) |
| 2023-06-09 | 2023-06-07 | 2023-06-07 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 3282.0 | 6.86 | 0.21 | 0.0 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code A | 47853.0 | 156.83 (CERE) |
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 23116.0 | 33.39 | 2.4 | 0.0 | Direct | Class A Common Stock | WARBY PARKER INC. | code A | 69231.0 | 96.43 (WRBY) |
| 2023-06-21 | 2023-06-20 | 2023-06-20 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 11.0 | 0.66 | 0.0 | 451.95 | Direct | Common Stock | ELI LILLY & CO | code A | 1674.0 | 949.27 (LLY) |
| 2023-06-29 | 2023-06-27 | 2023-06-27 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 642.0 | 14.82 | 0.01 | 0.0 | Direct | Class A Common Stock | MASTERCARD INC | code A | 4333.0 | 940.4 (MA) |
| 2023-07-18 | 2023-07-17 | 2023-07-17 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 11.0 | 0.65 | 0.0 | 447.14 | Direct | Common Stock | ELI LILLY & CO | code A | 1685.0 | 949.27 (LLY) |
| 2023-08-22 | 2023-08-21 | 2023-08-21 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 9.0 | 0.53 | 550.5 | Direct | Common Stock | ELI LILLY & CO | code A | 1694.0 | 949.3 (LLY) | |
| 2023-09-20 | 2023-09-18 | 2023-09-18 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 9.0 | 0.53 | 571.28 | Direct | Common Stock | ELI LILLY & CO | code A | 1706.0 | 949.3 (LLY) | |
| 2023-10-17 | 2023-10-16 | 2023-10-16 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 8.0 | 0.47 | 616.64 | Direct | Common Stock | ELI LILLY & CO | code A | 1714.0 | 949.3 (LLY) | |
| 2023-11-21 | 2023-11-20 | 2023-11-20 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 343.0 | 16.67 | 0.0 | 597.6 | Direct | Common Stock | ELI LILLY & CO | code A | 2057.0
|
949.31 (LLY) |
| 2023-12-19 | 2023-12-18 | 2023-12-18 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 9.0 | 0.43 | 579.76 | Direct | Common Stock | ELI LILLY & CO | code A | 2069.0 | 949.31 (LLY) | |
| 2024-01-17 | 2024-01-16 | 2024-01-16 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 16.0 | 0.77 | 0.0 | 634.57 | Direct | Common Stock | ELI LILLY & CO | code A | 2085.0 | 949.31 (LLY) |
| 2024-02-13 | 2023-12-31 | 2023-08-29 | 5 | Sulzberger Gabrielle | DIRECTOR | acq | 562.0 | 1.16 | 0.03 | 0.0 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code G | 48415.0 | 180.28 (CERE) |
| 2024-02-21 | 2024-02-20 | 2024-02-20 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 13.0 | 0.62 | 0.0 | 755.66 | Direct | Common Stock | ELI LILLY & CO | code A | 2098.0 | 949.31 (LLY) |
| 2024-03-19 | 2024-03-18 | 2024-03-18 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 13.0 | 0.61 | 0.0 | 762.66 | Direct | Common Stock | ELI LILLY & CO | code A | 2115.0 | 950.16 (LLY) |
| 2024-04-16 | 2024-04-15 | 2024-04-15 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 13.0 | 0.61 | 0.0 | 750.77 | Direct | Common Stock | ELI LILLY & CO | code A | 2128.0 | 950.16 (LLY) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-09 | 2023-06-07 | 2023-06-07 | 4 | Sulzberger Gabrielle | DIRECTOR | acq | 13780.0 | 100.0 | 0.88 | 32.6 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code A | 13780.0 | 156.83 (CERE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)